Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
levocarnitine
|
| gptkbp:ATCCode |
A16AA01
|
| gptkbp:CASNumber |
541-15-1
|
| gptkbp:chemicalFormula |
C7H15NO3
|
| gptkbp:contraindication |
hypersensitivity to levocarnitine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Carnitene
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sigma-Tau_Pharmaceuticals
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:pregnancyCategory |
Category B (US)
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal cramps |
| gptkbp:usedFor |
gptkb:secondary_carnitine_deficiency
gptkb:primary_carnitine_deficiency treatment of carnitine deficiency in patients with end-stage renal disease |
| gptkbp:bfsParent |
gptkb:Alfasigma
|
| gptkbp:bfsLayer |
8
|